BECTON DICKINSON AND CO (BDX) Stock Price, Forecast & Analysis
USA • New York Stock Exchange • NYSE:BDX • US0758871091
BDX Key Statistics, Chart & Performance
The current stock price of BDX is 201.91 USD. In the past month the price increased by 3.58%. In the past year, price decreased by -12.16%.
BDX Technical Analysis
ChartMill assigns a technical rating of 8 / 10 to BDX. When comparing the yearly performance of all stocks, BDX turns out to be only a medium performer in the overall market: it outperformed 41.05% of all stocks.
BDX Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to BDX. BDX scores excellent on profitability, but there are some minor concerns on its financial health.
BDX Financial Highlights
Over the last trailing twelve months BDX reported a non-GAAP Earnings per Share(EPS) of 14.42. The EPS increased by 9.57% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 7.68% | ||
| ROA | 3.03% | ||
| ROE | 6.61% | ||
| Debt/Equity | 0.73 |
BDX Forecast & Estimates
18 analysts have analysed BDX and the average price target is 212.38 USD. This implies a price increase of 5.18% is expected in the next year compared to the current price of 201.91.
For the next year, analysts expect an EPS growth of 4.17% and a revenue growth 2.91% for BDX
BDX Ownership
BDX Latest News, Press Relases and Analysis
BDX Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 21.24 | 190.25B | ||
| ISRG | INTUITIVE SURGICAL INC | 55.62 | 176.09B | ||
| SYK | STRYKER CORP | 27.01 | 140.78B | ||
| BSX | BOSTON SCIENTIFIC CORP | 31.14 | 136.19B | ||
| IDXX | IDEXX LABORATORIES INC | 48.94 | 51.07B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.16 | 47.96B | ||
| RMD | RESMED INC | 24.78 | 37.18B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 17.45 | 36.49B | ||
| DXCM | DEXCOM INC | 38.99 | 28.29B | ||
| PODD | INSULET CORP | 56.15 | 18.05B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 10.66 | 17.09B | ||
| HOLX | HOLOGIC INC | 17.46 | 16.66B |
Related stock screener links
About BDX
Company Profile
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 72,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
Company Info
BECTON DICKINSON AND CO
One Becton Drive
Franklin Lakes NEW JERSEY 07417 US
CEO: Thomas E. Polen
Employees: 74000
Phone: 12018476800
BECTON DICKINSON AND CO / BDX FAQ
Can you describe the business of BECTON DICKINSON AND CO?
Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. The company is headquartered in Franklin Lakes, New Jersey and currently employs 72,000 full-time employees. The firm is engaged in the development, manufacture and sale of a broad range of medical supplies, devices, laboratory equipment and diagnostic products used by healthcare institutions, physicians, life science researchers, clinical laboratories, and more. Its BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings. The BD Medical segment consists of various business units, including medication delivery solutions, medication management solutions, advanced monitoring, and pharmaceutical systems. Its BD Life Sciences segment provides products for the collection and transport of diagnostics specimens, and instruments and reagent systems to detect a range of infectious diseases, healthcare-associated infections and cancers. Its BD Interventional segment provides vascular, urology, oncology and surgical specialty products.
What is the current price of BDX stock?
The current stock price of BDX is 201.91 USD. The price decreased by -0.77% in the last trading session.
Does BECTON DICKINSON AND CO pay dividends?
BECTON DICKINSON AND CO (BDX) has a dividend yield of 2.09%. The yearly dividend amount is currently 4.16.
What is the ChartMill technical and fundamental rating of BDX stock?
BDX has a ChartMill Technical rating of 8 out of 10 and a ChartMill Fundamental rating of 5 out of 10.
How is the market expecting BDX stock to perform?
18 analysts have analysed BDX and the average price target is 212.38 USD. This implies a price increase of 5.18% is expected in the next year compared to the current price of 201.91.
What is the GICS sector and industry of BDX stock?
BECTON DICKINSON AND CO (BDX) operates in the Health Care sector and the Health Care Equipment & Supplies industry.
What is the ownership structure of BECTON DICKINSON AND CO (BDX)?
You can find the ownership structure of BECTON DICKINSON AND CO (BDX) on the Ownership tab.